BBY vs GILD · P/E 14, rev $18.71B vs P/E 18, rev $7.80B
Best Buy Co. Inc (BBY) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Best Buy Co. Inc (BBY) is a specialty retail company listed on NYSE.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported BBY revenue for 2026-08-01 was $18.71B. Net income was $591.0M. BBY currently screens at market cap $15.41B and trailing P/E 13.5.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
BBY currently screens at market cap $15.41B and trailing P/E 13.5. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the BBY and GILD stock pages for the full models.
Not investment advice.